Strategies to manage hepatitis C virus infection disease burden - volume 3

Autor:	M. T. Barakat, N. Nugrahini, Andri Sanityoso Sulaiman, S. El Khoury, Béla Hunyady, Y. Al Serkal, Liana Gheorghe, E. S. El Hassan, K. Saeed, M. Siddiq, H. Tarifi, A. Abdou, Homie Razavi, Fadi H. Mourad, Abdul Rahman Bizri, Do Young Kim, Matti Maimets, Devin Razavi-Shearer, S. Gregorcic, Ibrahim Altraif, Chris Estes, A. Salamat, Hamad I. Al-Ashgar, Riina Salupere, Sarah Blach, R. Husni, A. Sibley, F. Al Hosani, P. Aldins, S. Alawadhi, A. Baqir, S. Priohutomo, Mihály Makara, A. Abourached, A. Löve, Ieva Tolmane, Saeed Hamid, B. Karlsdottir, Adrian Goldis, Abdulrahman Aljumah, Samsuridjal Djauzi, Almoutaz Hashim, Laurentius A. Lesmana, Khalid Alswat, Jon G. Jonasson, Danute Speiciene, Young-Suk Lim, Arif Nawaz, M. Taha, R. Al-Hakeem, Abdullah S. Alghamdi, Rino Alvani Gani, Young Seok Kim, Abdullah M. Assiri, J. Videčnik-Zorman, A. Al Rifai, A. Sanityoso Sulaiman, Muhammad S. Memon, H. Fridjonsdottir, M. A. Al Mulla, Faisal M. Sanai, Faisal Abaalkhail, L. Al-Dabal, R. A. Sayegh, A. M. Siddiqui, Gabor Horvath, Moon Suk Choi, Cesar Yaghi, M. Sadik, Irsan Hasan, A. Almessabi, S. Fakhry, Zaigham Abbas, Ala I. Sharara, Evy Yunihastuti, Jacques E Mokhbat, David H. Muljono, Jonas Valantinas, Asad Chaudhry, K. Al Jaberi, H. Al Quraishi, B. Sigurdardottir, Altaf Alam, Mohamed A. Babatin, N. Andrea, F. Al Braiki, Kathryn Razavi-Shearer, Reza Malekzadeh, H. Qureshi, G. Sigmundsdottir, Marwa Sultan, Jonathan Schmelzer, Javed Iqbal Farooqi, Mojca Matičič, Junko Tanaka, S. Olafsson, Behzad Hajarizadeh, Shahin Merat, M. Alzaabi, Valentina Liakina, Adel Alqutub, Seyed M Alavian, G. Tayyab, M. Al Khatry, T. Diab, M. Ud Din, Jessie Gunter, Kwang Hyub Han, Faleh Z. Al-Faleh, Bader Faiyaz Zuberi, Wasim Jafri, P. Rassam, Magnus Gottfredsson, Baiba Rozentale, Agita Jeruma, A. Ghafoor Khan, M. Umar, Ottar M. Bergmann, Z. Koutoubi, M. A. Yusuf
Rok vydání:	2015
Předmět:	Adult Male medicine.medical_specialty Cure rate Pediatrics Asia Adolescent Hepatitis C virus medicine.disease_cause Antiviral Agents Infection disease Middle East Young Adult Virology medicine Prevalence Humans Child Disease burden Aged Aged 80 and over Harm reduction Models Statistical Hepatology business.industry Diagnostic Tests Routine Incidence Infant Newborn Infant Hepatitis C Chronic Middle Aged Treatment efficacy Drug Utilization Surgery Liver Transplantation Europe Infectious Diseases Child Preschool Communicable Disease Control Female Birth cohort business
Zdroj:	Journal of viral hepatitis. 22
ISSN:	1365-2893
Popis:	The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: increased treatment efficacy while holding the annual number of treated patients constant and increased treatment efficacy and an increased annual number of treated patients. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. A 90% reduction in total HCV infections within 15 years is feasible in most countries studied, but it required a coordinated effort to introduce harm reduction programmes to reduce new infections, screening to identify those already infected and treatment with high cure rate therapies. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. Among European countries, the majority of patients were born between 1940 and 1985. A wider range of birth cohorts was seen in the Middle East and Asia (between 1925 and 1995).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3284c2fb5b5af1bf865aa4b4b1da879c https://pubmed.ncbi.nlm.nih.gov/26513447 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.